Immunome, Inc.IMNMNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-151.35M
↓ 287% below average
Average (6y)
$-39.15M
Historical baseline
Range
High:$-7.18M
Low:$-151.35M
CAGR
+66.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-151.35M | -440.6% |
| 2023 | $-28.00M | +22.8% |
| 2022 | $-36.27M | -48.3% |
| 2021 | $-24.45M | -43.5% |
| 2020 | $-17.04M | -75.3% |
| 2019 | $-9.72M | -35.4% |
| 2018 | $-7.18M | - |